Cancer as the top employer health cost: what early visibility changes

Cancer has been the top condition driving employer health costs for five consecutive years; in the latest Business Group on Health survey 70% of employers name it their single largest driver. The employer learns about a case from the first treatment bill, months after the diagnosis. Ten pages on the survey evidence, treatment delay, guideline concordance, avoidable acute care, the benefits already bought, and what to ask for each quarter.

Arca

Cancer as the top employer health cost

Five years of employer surveys, the clinical price of a delay, and four measures a benefits team can ask its administrators for each quarter.

Cancer is the top employer health cost
The employer sees a cancer case last
A treatment delay is measurable in survival and in work
Guideline concordance costs less
Avoidable acute care during treatment
The benefits are bought and the cases go unmatched
What a benefits team should ask for

September 2026 · 10 pages · 20 sources

Get the paper

For benefits leaders at self-funded employers, and the advisors, TPAs and plan administrators who work with them.

Also in the library.

Oncology in Medicare Advantage: the care between the authorization and the claim The economics of cancer care coordination All guides and whitepapers

Tell us where your oncology risk sits.

Which contracts, which sites, and who manages the follow-through today. We reply within two business days with how Arca would run alongside them, starting with one program.

Talk to us Outcomes & economics